<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776247/" ref="ordinalpos=2561&amp;ncbi_uid=5502810&amp;link_uid=PMC3776247" image-link="/pmc/articles/PMC3776247/figure/F1/" class="imagepopup">Figure 1.  From: Dysregulation of JAK-STAT <span class="highlight" style="background-color:">pathway</span> in hematological malignancies and JAK inhibitors for clinical application. </a></div><br /><div class="p4l_captionBody"><b>Signaling cascade of JAK-STAT pathway.</b> Binding of the ligand to cytokine receptor induces receptor dimerization and activation of receptor associated JAK kinase, which in turn phosphorylates STAT proteins. After forming a homodimer, STAT proteins translocate to the nucleus to control gene expression. Negative regulation of the JAK-STAT pathway is provided by phospho-tyrosine phosphatases (PTP), member for SOCS family proteins and PIAS proteins (shown in red).</div></div>